Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes

Journal of Immunotherapy

Volumn 21, Issue 5, 1998, Pages 340-351

  Eue, Ines ^a   Kumar, Rakesh ^a   Dong, Zhongyun ^a   Killion, Jerald J ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Lipopeptide; Macrophages; Multipotential tumoricidal activation

Indexed keywords

GAMMA INTERFERON; LIPOPEPTIDE; LIPOSOME; MURAMYL DIPEPTIDE; NITRIC ACID; S (2,3 DIDODECANOYLOXYPROPYL) N HEXADECANOYLCYSTEINYLALANYL DEXTRO ISOGLUTAMINYLGLYCYLTAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTINEOPLASTIC ACTIVITY; ARTICLE; IMMUNOMODULATION; KNOCKOUT MOUSE; LIVER METABOLISM; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE FUNCTION; NONHUMAN; OSTEOBLAST; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SARCOMA;

EID: 0031657036     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199809000-00002     Document Type: Article

References (42)

1. Fidler IJ. Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res 1985;45:4714-26.
2. Fidler IJ, Schroit AJ. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 1988;948:151-73.
3. Fidler IJ. Therapy of cancer metastasis by systemic activation of macrophages. Adv Pharmacol 1994;30:271-326.
4. Fidler IJ. Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer. Adv Drug Del Rev 1988;2:69-106.
5. Koff WC, Fidler IJ. The potential use of liposome-mediated antiviral therapy. J Antiviral Res 1985;228:495-7.
6. Fidler IJ, Kleinerman ES. Clinical application of phospholipid liposomes containing macrophage activators for therapy of cancer metastasis. Adv Drug Del Rev 1994; 13:325-410.
7. MacEwen EG, Kurzman ID, Rosenthal RC, et al. Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. J Natl Cancer Inst 1989;81: 935-8.
8. MacEwen EG, Kurzman ID, Helfand S, et al. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progressive review. J Drug Targeting 1989;81:935-8.
9. Kleinerman ES, Murray JL, Snyder JS, Cunningham JE, Fidler IJ. Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine. Cancer Res 1989;49:4665-70.
10. Kleinerman ES, Snyder JS, Jaffe N. Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma. J Clin Oncol 1991:9:259-67.
11. Kleinerman ES. Raymond AK, Bucana CD, et al. Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid). Cancer Immunol Immunother 1992;34:211-20.
12. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;78:319-30.
13. 2 by human blood monocytes subsequent to interaction with different bacterial derived agents. Lymphokine Res 1990;9:449-54.
14. Utsugi T, Nii A, Fan D, et al. Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages. Cancer Immunol Immunother 1991;33:285-92.
15. Utsugi T, Dinney CPN, Killion JJ, Fidler IJ. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP31362. Cancer Immunol Immunother 1991;33:375-81.
16. Nii A, Utsugi T, Fan D, et al. Optimization of the liposomes encapsulating a new lipopeptide CGP 31362 for efficient activation of tumoricidal properties in monocytes and macrophages. J Immunother 1991; 10:236-46.
17. Dinney CPN, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362. Cancer Res 1991;51:3741-7.
18. Dinney CPN, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ. Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or 7-interferon. Cancer Res 1992;52:1155-61.
19. MacMiking JD, Nathan C, Horn G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-50.
20. Talmadge JE, Fidler IJ. Cancer metastasis is selective or random depending on the parent tumor population. Nature 1982;27:593-4.
21. Dong Z, Radinsky R, Fan D, et al. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 1994;86:913-20.
22. Kozlowski JM, Hart IR, Fidler IJ, Hanna N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst 1984;72:913-7.
23. Saiki I, Fidler IJ. Synergistic activation of recombinant mouse interferon-γ and muramyl dipeptide of tumoricidal properties in mouse macrophages. J Immunol 1985;135:684-8.
24. Dong Z, Qi X, Fidler IJ. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J Exp Med 1993;177:1071-7.
25. Ding AE, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 1988;141:2407-12.
26. Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res 1982;42:161-9.
27. Weinstein SL, Gold MR, DeFranco L. Bacterial LPS stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991;88:4148-52.
28. Dong Z, O’Brian CA, Fidler IJ. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires proteintyrosine kinase activity. J Leukoc Biol 1993;53:53-60.
29. Xie K, Huang S, Dong Z, Gutman M, Fidler IJ. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP31362. Cancer Res 1995;55:3123-31.
30. Watson J, Kelly K, Largen M, Taylor BA. The genetic mapping of a defective LPS gene in C3H/HeN mice. J Immunol 1978; 120: 422-5.
31. Chedid L, Parant M, Damais C, Parant F, Juy D, Galelli A. Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder mice. Infect Immunol 1976; 13: 722-6.
32. Dong Z, Qi X, Fidler IJ. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and Iipopolysaccharide-nonresponsive murine macrophages. J Immunol 1993;151:2717-25.
33. Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Pelech SL. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J BiolChem 1992;267:14955-63.
34. Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res 1982;42:161-7.
35. Weinstein SL, June CH, DeFranco AL. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol 1993;151:3829-33.
36. Stefanova I, Horejsi IJ, Ansotegui IJ, Knapp W, Stockinger H. GPI anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991;254:1016-7.
37. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 1990;249:1431-2.
38. Fidler IJ. Macrophages. In: Bertino JR, ed. Encyclopedia of cancer, vol II. Orlando, FL: Academic Press, 1997:1031-41.
39. Xie K, Huang S, Dong Z, et al. Transfection of inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis in K-1735 murine melanoma. J Exp Med 1995; 181:1333-44.
40. Dinney CPN, Fidler IJ. Biology of metastasis: studies in renal cancer. In: Raghaven D, Scher HI, Leibel SA, Lange P, eds. Principles and practice of genitourinary oncology. Philadelphia: Lippincott-Raven, 1996:17-24.
41. Niewoehner DE, Rice K, Sinha AA, Wangensteen D. Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium. J Appl Physiol 1987;63:1979-86.
42. Arbibe L, Vial D, Rosinski-Chupin I, et al. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs. J Immunol 1997;159:391-400.